Syphilis Diagnosis and Interest in Doxycycline Postexposure Prophylaxis Among Young Black Sexual and Gender Minorities

年轻黑人性少数群体和性别少数群体对梅毒诊断及多西环素暴露后预防的兴趣

阅读:4

Abstract

BACKGROUND: Doxycycline postexposure prophylaxis (doxy-PEP) is a low-cost, effective strategy for preventing syphilis and other bacterial sexually transmitted infections among men who have sex with men and transgender women, yet doxy-PEP remains underused by young black sexual and gender minorities (YBSGM). This analysis examined sociodemographic, sexual health, and substance use factors associated with interest in doxy-PEP among a human immunodeficiency virus (HIV) status-neutral cohort of YBSGM. METHODS: The Neighborhoods and Networks Phase 2 (N2P2) cohort included YBSGM, and our primary outcome was interest in doxy-PEP. Generalized linear models were fit to calculate the unadjusted and adjusted relative risks (RRs) between interest in doxy-PEP and sociodemographic and health factors. RESULTS: A total of 538 participants were included in the analysis, with 59.9% reporting interest in doxy-PEP. Participants interested in doxy-PEP were older (RR, 1.02 [95% confidence interval (CI), 1.00-1.04]; P = .04), more likely to be living with HIV (1.25 [1.08-1.44]; P < .01), and more likely to have a history of syphilis (1.45 [1.23-1.70]; P < .01). Self-report stimulant use (RR, 1.28 [95% CI, 1.15-1.53]; P < .01) and group sex (1.32 [1.15-1.53]; P < .01) were greater among those interested in doxy-PEP. When adjusted for age, HIV status, and stimulant use, history of syphilis (adjusted RR, 1.17 [95% CI, 1.05-1.31]; P = .01) and group sex (1.14 [1.02-1.28]; P = .02) remained associated with interest in doxy-PEP. CONCLUSIONS: YBSGM who were interested in doxy-PEP were more likely to have had a syphilis diagnosis and participate in group sex. YBSGM with these risk factors represent an important demographic for the scale-up of doxy-PEP use.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。